期刊文献+

HIV患者抗病毒治疗前后体内Hcy、免疫球蛋白、β_(2)微球蛋白等指标的变化分析

An Analysis of Changes of Hcy,Immunoglobulin,β_(2) Microglobulin and Other Indicators in HIV Patients Before and After Antiviral Treatment
下载PDF
导出
摘要 目的探究HIV患者抗病毒治疗前后体内同型半胱氨酸(Hcy)、免疫球蛋白G(IgG)和β_(2)微球蛋白(β_(2)-MG)等指标的变化分析。方法选取我院进行检查并住院进行抗病毒治疗的87例HIV患者(2019年1月至2020年5月)作为研究目标。通过分析初诊时和治疗后患者血清中Hcy、β_(2)-MG表达水平、免疫球蛋白表达水平、γ-GT、LACT表达水平、T细胞亚群的差异性来探究HIV感染患者抗病毒治疗前后体内同型半胱氨酸(Hcy)、免疫球蛋白G(IgG)和β_(2)微球蛋白(β_(2)-MG)等指标的变化分析。结果初诊时和治疗后相比较,初诊时患者免疫球蛋白表达水平显著高于治疗后(P<0.05)。初诊时患者T细胞亚群CD3、CD4、CD8表达分别为(53.84±6.47)%、(33.52±3.65)%、(23.67±2.82)%,治疗后患者体内CD3、CD4、CD8表达分别为(64.65±6.42)%、(2.31±4.83)%、(27.78±3.89)%,初诊时患者T细胞亚群表达水平低于治疗后(P<0.05),CD4^(+)/CD8^(+)比值相差较小(P>0.05)。初诊时和治疗后相比较,初诊时患者Hcy、β_(2)-MG表达水平明显高于治疗后(P<0.05)。初诊时患者γ-GT、LACT表达分别为112.65±21.14U/L、4.35±1.28mmol/L,治疗后患者体内γ-GT、LACT表达分别为140.72±32.25U/L、1.33±0.27mmol/L,初诊时患者LACT表达水平明显高于治疗后(P<0.05),而初诊时患者γ-GT表达水平低于治疗后(P<0.05)。结论HIV感染患者抗病毒治疗后体内T细胞亚群、免疫球蛋白表达水平等免疫指标均出现显著改变,同时,Hcy、β_(2)-MG、LACT表达水平明显下降,γ-GT表达水平显著上升,因此,在临床研究中,可以通过检测上述指标进行艾滋病患者的诊断及治疗,建议推广使用。 Objective To explore changes of homocysteine(Hcy),immunoglobulin G(IgG)andβ_(2) microglobulin(β_(2)-MG)in HIV-infected patients before and after antiviral treatment.Methods 87 HIV patients(from Jan.2019.to May 2020)who were examined and hospitalized for antiviral treatment in our hospital were selected as the research subjects.By analyzing the differences in serum Hcy,β_(2)-MG expression levels,immunoglobulin expression,γ-GT,LACT expression levels,and T cell subsets in patients at the time of initial diagnosis and after treatment,we studied the homotype and half of HIV-infected patients before and after antiviral treatment.We conducted analysis of changes in indicators,such as cystine(Hcy),immunoglobulin G(IgG)and β_(2) microglobulin(β_(2)-MG).Results Compared with the first diagnosis and after treatment,the expression level of immunoglobulin in the first diagnosis was significantly higher than that after treatment(P<0.05).Expressions of T cell subsets CD3,CD4,CD8 of patients at the first diagnosis were(53.84±6.47)%,(33.52±3.65)%,(23.67±2.82)%,and expressions of CD3,CD4,and CD8 were(64.65±6.42)%,(42.31±4.83)%,(27.78±3.89)%after treatment.The expression level of T cell subsets was lower than that after treatment(P<0.05),and the difference in the ratio of CD4^(+)/CD8^(+)was small(P>0.05).Compared with the first diagnosis and after treatment,expression levels of Hcy andβ_(2)-MG in the first diagnosis were significantly higher than those after treatment(P<0.05).The expressions ofγ-GT and LACT were 112.65±21.14U/L and 4.35±1.28mmol/L at the time of initial diagnosis.After treatment,expressions ofγ-GT and LACT were 140.72±32.25U/L and 1.33±0.27mmol/L,respectively.The expression level of LACT at the first diagnosis was significantly higher than that after treatment(P<0.05),while the expression level ofγ-GT at the first diagnosis was lower than that after treatment(P<0.05).Conclusion After antiviral treatment of HIV-infected patients,immune indicators,such as T cell subsets and immunoglobulin expression levels,are significantly changed.At the same time,expression levels of Hcy,β_(2)-MG,and LACT are decreased significantly,and the expression level ofγ-GT is increased significantly.Therefore,in clinical research,the above indicators can be used to diagnose and treat AIDS patients,and it is recommended to promote its application.
作者 张珍 孟娟 范伟光 杨学刚 ZHANG Zhen;MENG Juan;FAN Weiguang;YANG Xuegang(Baoding People’s Hospital of North Province,Baoding 071000,China)
出处 《标记免疫分析与临床》 CAS 2024年第2期341-345,共5页 Labeled Immunoassays and Clinical Medicine
关键词 HIV 同型半胱氨酸 免疫球蛋白 β_(2)微球蛋白 HIV Homocysteine Immunoglobulin β2microglobulin
  • 相关文献

参考文献13

二级参考文献132

  • 1王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:632
  • 2陈海雁.急性危重病患者血乳酸(LACT)与血气检测的临床应用[J].临床和实验医学杂志,2007,6(7):91-91. 被引量:34
  • 3彭庭海,詹发先,褚小刚,汤恒.湖北省健康青少年及成人外周血T淋巴细胞正常值研究[J].中国艾滋病性病,2007,13(5):414-416. 被引量:10
  • 4WS293-2008.艾滋病和艾滋病病毒感染诊断标准[S].2008.
  • 5UNAIDS. AIDS epidemicupdate: November 2009 [EB/OL]. ht- tp://data, unaids, org/pub/Report/2009/2009_ epidemic update _en. Pdf.
  • 6Poriehis F,Kaufmann DE. HIV-specific CD4 T cells and immune control of viral replication[J]. Curr Opin HIV AIDS,2011,6(3) 174-180.
  • 7Freel SA,Saunders KO,Tomaras GD. CDs+ T-cell-mediated con- trol of HIV-1 and SIV infection[J]. Immunol Res, 2011, 49(1 3) : 135-146.
  • 8van Bockel DJ,Price DA,Munier ML,et al. Persistent survival of prevalent clonotypes within an immunodominant HIV gag-specific CDs+ T cell response[J]. J Immunol, 2011, 186(1):359- 371.
  • 9Xu S, Song A, Nie J, et al. Comparative Evaluation of the CO- BAS AmpliPrep/COBAS TaqMan HIV Type 1 Test (CAP/ CTM) and VERSANT HIV Type 1 RNA 3.0 Assay (bDNA) for Quantifying HIV Type 1 Viral Loads in China[J]. AIDS research and human retroviruses, 2008, 24(11) : 1365-1373.
  • 10Schumacher W, Frick E, Kauselmann M, et al. Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in hu-man plasma by the COBAS AmpliPrep/COBAS Taq- Man system[J]. J Clin Virol, 2007, 38(4): 304-312.

共引文献436

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部